SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-044908
Filing Date
2023-12-14
Accepted
2023-12-14 17:10:31
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4560
  Complete submission text file 0001493152-23-044908.txt   6197
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Issuer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MOATAZEDI DAVID (Reporting) CIK: 0001700836 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37863 | Film No.: 231487906